The trajectory of Viagra, initially marketed by copyright, presents a complex case study for investors considering the pharmaceutical landscape . Despite its early success and creation of billions in earnings , the intellectual property expiration has opened the floodgates for alternative medications, substantially eroding earnings potential escort